O T C
Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com   Plantation, Florida, April 15, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing

PsyKey Inc Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development

Las Vegas, Nevada, April 14, 2021 – OTC PR WIRE – CECORS, INC. (OTC PINK: CEOS) (“CeCors” or the “Company”), is pleased to announce that its wholly-owned Canadian subsidiary PsyKey Inc. has entered into a letter of intent with MycoVita Canada Inc. (“MycoVita”) to form a strategic partnership. The PsyKey – MycoVita strategic partnership will

Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product

London, UK, April 14, 2021 – OTC PR WIRE — Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the launch of DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms

Epidemiologic Solutions Corporation (ESC), an IRS approved, qualified public charity, announces its funding for its “pain-free-veterans” initiative

  Westlake, LA, April 14, 2021 – OTC PR WIRE –  Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of PainplexTM an all-herbal extraction developed by Gold River

PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

  Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived

Eyecity.com, Inc. (ICTY) and CGrowth Capital Inc. (CGRA) Announce Partnership Initiatives on 47-acre Cannabis Industrial Complex in Washington State

    Land of Lakes, Florida, April 13, 2020) – OTC PR WIRE – Eyecity.com Inc. (OTC Pink: ICTY) (“ICTY”), a holding company with projects in the cannabis, hospitality, commercial and residential development industries both in the United States and Internationally; and CGrowth Capital, Inc. (OTC Pink: CGRA) (“CGRA”), an alternative asset holding company with

PURA Schedules Update To Follow Upcoming Annual RPT Highlighting Increasing Interest In ALKM, Breaking Ground In Farmersville, And PAOG and USMJ Partnerships

Dallas, TX, April 12, 2021 – OTC PR WIRE – Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20th, 2021 to follow the upcoming FY2021 Annual Report coming later this week. The update will highlight PURA’s commitment to striking on an opportunity to increase its ownership in Alkame Holdings, Inc. above

PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

  Sandusky, OH, April 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is

SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.

  Scottsdale, Arizona, April 12, 2021 – OTC PR WIRE – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: Sibannac, Inc. and Stellar Chemical Corp. (“Stellar”), a New Jersey based nutraceutical and industrial chemical manufacturer, have entered into a Memorandum of Understanding for Sibannac to acquire 51% of Stellar in

YEP enters into Globally Exclusive Letter of Intent with Wellness Labs for specialized PPE, Hydration Systems, and CBD Products

Leawood, Kansas, April 9, 2021 – OTC PR WIRE — YEP, Inc., (“YEP”) an innovative sales and marketing company, announced today that it has entered an exclusive Letter of Intent with Wellness Labs LLC for the manufacture and supply of (1) Micelle Nano CBD products including proprietary CBD beverages, (2) FLUX DRINKABLES, a 100% sustainable,

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019